PBLSNasdaqPharmaceutical Preparations

Parabilis Medicines, Inc. (PBLS) earnings date, market-implied expected move, and options open interest by expiry

29.35

+2.10 · +7.70%

Regular session14:24 ET

Open27.00Volume702,259Mkt cap$787.8M

Day27.00 – 29.35100%52-wk22.66 – 42.4934%

PBLS

Parabilis Medicines, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Next report

—

Calendar

Last report

−4.65%

shaded = implied · ▲▼ = realized

Aug 13 '26 · confirmed

Implied vs realized

Linked news

4dREGN · customerRegeneron reports Q3 net income $1,948.7 million, revenues $5,115.8 million

News

Largest filed tie

13F top-10 QoQ

—

79 managers

Top fund weight

0.00%

PBLS weight · VTI

N-PORTJun 30 '26

1 fund

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

No upcoming report date for Parabilis Medicines (PBLS).

Implied vs realized

1 report

—≥ implied

Q2 FY26Aug 13 '26confirmed—▼−4.65%—

quarterimplied−5%0+5%realized×

Q2 FY26—▼−4.65%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 2 expiries · Oct 21 close

0.62OI · 2 expiries · Oct 21 closeP/C open interest · Nov 20 · nearest expiry

PUTS · chgexpiry · days · P/CCALLS · chgP/C

64+5%Nov 2017d104+73%

24−4%Feb 19108d0.102480%0.10

ExpiryPutsCallsP/C

Nov 2017d64+5%104+73%0.62

Feb 19108d24−4%2480%0.10

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ2 FY26

−70895.95%as filednet margin · revenue −85.93% YoY

Revenue$148,000—

Gross profit$148,000100.00%—

Operating income−$51M−34382.43%—

Pre-tax income−$52M—

Net income−$105M−70895.95%—

Cost of revenue$0—

Operating expenses$51M—

Other expense−$2M—

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 14:15 ET

Intraday

Event sensitivity

—

Earnings history

EPS -2.32 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 13 '26 · confirmed	-2.32	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod